Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

The lower limit of oxygen concentration of coal under different air leakage intensities. by Zihao Chai (20521844)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Maximal air leakage intensity under different thickness of the loose coal body. by Zihao Chai (20521844)

Subjects:

Nancy Index. by Leyla Tekin (21492873)

Subjects:

Apparent activation energy of coal samples under different experimental conditions. by Zihao Chai (20521844)

Subjects:

The characteristics of 52 studies included in the systematic review and meta-analysis. by Alemneh Mekuriaw Liyew (9216921)

Subjects:

O₂ concentration under different conditions. by Zihao Chai (20521844)

Subjects:

Fig 6 - by Maryann S. Watson (16879881)

Subjects:

Scatter plots of photo score by age and blue reaction time. by Richard C. Trevino (22676460)

Subjects:

Dynamics of PIF4 protein accumulation and autoinhibition in response to temperature. by Sreya Das (20531295)

Subjects:

Percentage inhibition of hemolysis by 6-shogaol-rich ginger extract (0–200 µg/mL) and ascorbic acid (AA; 100 µg/mL) in red blood cells obtained from thalassemia patients (A) and he... by Hataichanok Chuljerm (19144293)

Subjects:

Primer sequences used for Real-Time quantitative PCR. by Haoyang Zhang (1706815)

Subjects:

Risk factors for <i>Schistosoma haematobium</i> infection. by Lydia Trippler (10136316)

Subjects: